280K funding boost for research into little known blood cancer

280K funding boost for research into little known blood cancer

Researchers from the University of Aberdeen and Queen's University Belfast have been awarded a £280,000 funding boost from Blood Cancer UK. It forms part of Blood Cancer UK's latest funding for the illness, which is the fifth most common cause of cancer in the UK.

Relatively little is known about the causes of a group of blood cancer called myeloproliferative neoplasms (MPN), affecting approximately 4,000 people in the UK every year.

During MPN your body produces too many of a particular blood cell. While little is known about the causes of MPNs, research has shown many cancers are caused by genetic alterations that people are born with as well as things that they are exposed to during their life.  

Professor Lesley Anderson and her team plan to look at data and samples from people with MPN to identify small changes in our DNA that might be responsible for causing the disease.

She also hopes to combine this and look at other environmental factors such as where these people live, what job they do and other factors as these things can “turn on” or “turn off” genes, which can also influence the chance of someone developing some cancers.

Using the world’s largest case-control study of MPNs (the MOSAICC study) where one group has MPN and the other doesn’t, the team will look at interactions between genes and the environment. The work will also include 50 samples of a new approach to identify these genetic and environmental changes.

Professor Lesley Anderson from the University of Aberdeen said: “This research is important as it has the potential to help increase our understanding of how MPN develops. Using data and samples from patients across the UK could help us prevent MPNs, improve diagnosis and develop new and better ways to treat people with the disease. Ultimately it could mean that people with MPNs can be diagnosed faster and given better treatments that more effectively target the cancer.”

Sarah McDonald, Deputy Director of Research at Blood Cancer UK,  said: “Blood cancer is the fifth most common cause of cancer in the UK, with 40,000 diagnosed every year, yet so many people are unaware that MPNs are a blood cancer. Understanding the genetics underpinning the development of blood cancers will help us develop new treatments against the disease.”

ENDS

Search News

Browse by Month

2024

  1. Jan
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug There are no items to show for August 2024
  9. Sep There are no items to show for September 2024
  10. Oct There are no items to show for October 2024
  11. Nov There are no items to show for November 2024
  12. Dec There are no items to show for December 2024

2018

  1. Jan There are no items to show for January 2018
  2. Feb
  3. Mar
  4. Apr There are no items to show for April 2018
  5. May
  6. Jun
  7. Jul There are no items to show for July 2018
  8. Aug
  9. Sep
  10. Oct
  11. Nov
  12. Dec

2017

  1. Jan
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug
  9. Sep
  10. Oct
  11. Nov
  12. Dec There are no items to show for December 2017

2015

  1. Jan There are no items to show for January 2015
  2. Feb There are no items to show for February 2015
  3. Mar There are no items to show for March 2015
  4. Apr There are no items to show for April 2015
  5. May There are no items to show for May 2015
  6. Jun There are no items to show for June 2015
  7. Jul There are no items to show for July 2015
  8. Aug There are no items to show for August 2015
  9. Sep
  10. Oct
  11. Nov
  12. Dec